Judgment of the General Court (Second Chamber) of 24 May 2023.#Glaxo Group Ltd v European Union Intellectual Property Office.#EU trade mark – Invalidity proceedings – Three-dimensional EU trade mark – Shape of an inhaler – Absolute ground for invalidity – Distinctive character acquired through use – Article 51(2) of Regulation (EC) No 40/94 (now Article 59(2) of Regulation (EU) 2017/1001) – Obligation to state reasons – Article 94 of Regulation 2017/1001.#Case T-477/21.